Centiva Capital’s Biohaven BHVN Stock Holding History

Centiva Capital’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-41,800	Closed	-$590K	–	1139
2025 Q2	$590K	Buy	+41,800	New	+$745K	0.01%	891

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Centiva Capital's BHVN Position: Q3 2025 in Review

Centiva Capital sold out of Biohaven (BHVN) in Q3 2025, closing a stake of 17,900 shares — an estimated $253K sold.

Centiva Capital first reported a position in BHVN in Q2 2025 and held it in 1 quarter. The position peaked at $253K in Q2 2025. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

Centiva Capital reported no remaining Biohaven position as of Q3 2025 after selling out during the quarter.
Centiva Capital sold 17,900 Biohaven shares in Q3 2025, an estimated $253K.
Centiva Capital first reported a position in Biohaven in Q2 2025 and held it in 1 quarter.
Centiva Capital's Biohaven position peaked at $253K in Q2 2025.
264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.